|
Exhibit 99.1 |
|
 |
News Release |
For Further Information Call:
John P. Jordan
Vice President, Chief Financial Officer & Treasurer
Voice: 860-347-8506
inquire@zygo.com
ZYGO REPORTS $40 MILLION REVENUE, $0.13 EPS for Q1 Fiscal 2013
MIDDLEFIELD, Conn, November 9, 2012 – Zygo Corporation (Nasdaq: ZIGO) today announced its financial results for the first quarter of fiscal 2013 ended September 30, 2012 and points out the following highlights for the quarter:
|
|
|
| • | Bookings of $37.3 million increased 5% from the fourth quarter of fiscal 2012. |
| • | Acquired the 40% minority-owned portion of our European sales and application center joint venture, establishing it as a wholly-owned subsidiary in Germany. |
| • | Established a Taiwan subsidiary as a sales, service and manufacturing facility to support growth of Asian business including semiconductor advanced packaging 2D/3D inspection and metrology systems. |
Revenue in the fiscal 2013 first quarter was $40.2 million compared to $44.0 million in the comparable prior year quarter and $44.3 million in fiscal 2012 fourth quarter.
Net income for fiscal 2013 first quarter was $2.4 million, or $0.13 per diluted share, compared to $6.5 million or $0.35 per diluted share recorded in the first quarter of fiscal 2012.
Bookings for the first quarter of fiscal 2013 were $37.3 million, compared to $42.9 million in the first quarter of fiscal 2012 and $35.5 million in the previous quarter. Bookings for the Metrology Solutions Division were 68% of the total; Optical Systems Division bookings were 32%. Backlog was $65.1 million at September 30, 2012, compared to $60.9 million at September 30, 2011 and $68.0 million at June 30, 2012.
Commenting on the first quarter results, John P. Jordan, Vice President, Chief Financial Officer and Treasurer of Zygo Corporation, said, “Zygo’s product line and customer diversification enabled us to deliver revenue of $40.2 million in the face of continued weak demand in the semiconductor sector. Gross margins were lower during the quarter due to the effect of a change in product mix within both metrology and optics segments, combined with the effect of an initial ramp-up of a large new optics program.
“In addition, the previous years’ results benefitted from the offset effect of reversing valuation allowance against tax provision, essentially eliminating U.S. Federal income tax expense. Since the valuation allowance against deferred
1
tax assets was eliminated at the end of fiscal 2012 due to improved operating performance and improved business outlook, current year results reflect tax expense at the full effective tax rate. As set forth in the Reconciliation of Reported Results to Non-GAAP Results in this Press Release, the tax provision for the current year quarter also included items that reduced the effective tax rate to 32.4% and increased Earnings per Share by $0.03. It should be noted that although the tax rate has increased for financial statement purposes, cash taxes actually paid will remain at approximately 11% of pretax income until the past net operating losses and available credits are fully utilized on the Company’s tax returns.”
Dr. Chris Koliopoulos, President and Chief Executive Officer of Zygo Corporation, commented, “Economic uncertainty in the U.S. and abroad has deferred investments in capital equipment and expansion. Although demand in some markets has continued to lag expectations, we are investing in new markets and growing our footprint in strong market regions, as demonstrated by our initiatives in Germany and Taiwan. As a result of the acquisition of the minority interest of our German subsidiary, beginning with the first quarter, 100% of the income generated by our now wholly-owned German operation will be included in Zygo net income. Additionally, we continue investment in optics capabilities in our new facility in Tucson to take advantage of opportunities in an anticipated recovering economic environment during the second half of the fiscal year.”
Zygo Corporation is a worldwide supplier of optical metrology instruments, precision optics and electro-optical design and manufacturing services serving customers in the semiconductor capital equipment, bio-medical, scientific and industrial markets.
Note: Zygo’s teleconference to discuss the results of the first quarter of fiscal 2013 will be held at 5 PM Eastern Time on November 9, 2012 and can be accessed by dialing (800) 616-4707. This call is web cast live on Zygo’s web site atwww.zygo.com. The call may also be accessed for 30 days following the teleconference.
2
Forward-Looking Statements
All statements other than statements of historical fact included in this news release regarding financial performance, condition and operations and the business strategy, plans, anticipated revenues, bookings, market acceptance, growth rates, market opportunities and objectives of management of the Company for future operations are forward-looking statements. Forward-looking statements provide management's current expectations or plans for the future operating and financial performance of the Company based upon information currently available and assumptions currently believed to be valid. Forward-looking statements can be identified by the use of words such as “anticipate,” “believe,” “estimate,” “expect,” “intend,” “plan(s),” “strategy,” “project,” “should” and other words of similar meaning in connection with a discussion of current or future operating or financial performance. Actual results could differ materially from those contemplated by the forward-looking statements as a result of certain factors. Among the important factors that could cause actual events to differ materially from those in the forward-looking statements are fluctuations in capital spending of our customers; fluctuations in revenues to our major customers; manufacturing and supplier risks; risks of booking cancellations, push-outs and de-bookings; dependence on timing and market acceptance of new product development; rapid technological and market change; risks in international operations; risks related to the reorganization of our business; dependence on proprietary technology and key personnel; length of the revenue cycle; environmental regulations; investment portfolio returns; fluctuations in our stock price; the risk that anticipated growth opportunities may be smaller than anticipated or may not be realized; and risks related to business acquisitions. Zygo Corporation undertakes no obligation to publicly update or revise forward-looking statements to reflect events or circumstances after the date of this news release except as required by law. Further information on potential factors that could affect Zygo Corporation's business is described in our reports on file with the Securities and Exchange Commission, including our Form 10-K for the fiscal year ended June 30, 2012, filed with the Securities and Exchange Commission on September 13, 2012.
3
|
Zygo Corporation and Subsidiaries |
(Unaudited) |
|
(Amounts in thousands, except per share amounts) |
|
|
|
|
|
|
|
|
|
| Three Months Ended |
| ||||
|
|
| |||||
|
| 2012 |
| 2011 |
| ||
|
|
|
| ||||
Net revenue |
| $ | 40,206 |
| $ | 43,992 |
|
Cost of goods sold |
|
| 22,713 |
|
| 22,375 |
|
|
|
|
| ||||
Gross profit |
|
| 17,493 |
|
| 21,617 |
|
|
|
|
| ||||
Selling, general and administrative expenses |
|
| 8,521 |
|
| 9,463 |
|
Research, development and engineering expenses |
|
| 4,581 |
|
| 4,062 |
|
|
|
|
| ||||
Operating profit |
|
| 4,391 |
|
| 8,092 |
|
|
|
|
| ||||
Other income (expense) |
|
|
|
|
|
|
|
Miscellaneous income (expense), net |
|
| 36 |
|
| (330 | ) |
|
|
|
| ||||
Total other income (expense) |
|
| 36 |
|
| (330 | ) |
|
|
|
| ||||
Income before income tax, including noncontrolling |
|
| 4,427 |
|
| 7,762 |
|
Income tax expense |
|
| (1,433 | ) |
| (786 | ) |
|
|
|
| ||||
Net income including noncontrolling interest(s) |
|
| 2,994 |
|
| 6,976 |
|
Less: Net income attributable to noncontrolling interest(s) |
|
| 606 |
|
| 507 |
|
|
|
|
| ||||
Net income attributable to Zygo Corporation |
| $ | 2,388 |
| $ | 6,469 |
|
|
|
|
| ||||
|
|
|
|
|
|
|
|
Earnings per share attributable to Zygo Corporation |
|
|
|
|
|
|
|
Basic shares |
| $ | 0.13 |
| $ | 0.36 |
|
|
|
|
| ||||
Diluted shares |
| $ | 0.13 |
| $ | 0.35 |
|
|
|
|
| ||||
Weighted average shares outstanding |
|
|
|
|
|
|
|
Basic shares |
|
| 18,341 |
|
| 17,800 |
|
|
|
|
| ||||
Diluted shares |
|
| 19,047 |
|
| 18,353 |
|
|
|
|
| ||||
4
|
Zygo Corporation and Subsidiaries |
Condensed Consolidated Balance Sheets |
(Unaudited) |
|
(Amounts in thousands) |
|
|
|
|
|
|
|
|
|
| September 30, 2012 |
| June 30, 2012 |
| ||
|
|
|
| ||||
Assets |
|
|
|
|
|
|
|
Current assets: |
|
|
|
|
|
|
|
Cash and cash equivalents |
| $ | 78,834 |
| $ | 84,053 |
|
Receivables, net |
|
| 29,991 |
|
| 31,601 |
|
Inventories |
|
| 27,507 |
|
| 27,760 |
|
Prepaid expenses and other current assets |
|
| 2,567 |
|
| 2,851 |
|
Revenue recognized in excess of billings on uncompleted contracts |
|
| 4,473 |
|
| 2,371 |
|
Deferred income taxes |
|
| 9,788 |
|
| 8,004 |
|
|
|
|
| ||||
Total current assets |
|
| 153,160 |
|
| 156,640 |
|
Marketable securities |
|
| 718 |
|
| 729 |
|
Property, plant and equipment, net |
|
| 33,342 |
|
| 33,694 |
|
Deferred income taxes |
|
| 13,768 |
|
| 13,760 |
|
Intangible assets, net |
|
| 4,983 |
|
| 5,198 |
|
|
|
|
| ||||
Total assets |
| $ | 205,971 |
| $ | 210,021 |
|
|
|
|
| ||||
|
|
|
|
|
|
|
|
Liabilities and Equity |
|
|
|
|
|
|
|
Current liabilities: |
|
|
|
|
|
|
|
Accounts payable |
| $ | 8,061 |
| $ | 9,613 |
|
Accrued expenses |
|
| 14,046 |
|
| 18,914 |
|
Income tax payable |
|
| 648 |
|
| 416 |
|
|
|
|
| ||||
Total current liabilities |
|
| 22,755 |
|
| 28,943 |
|
|
|
|
|
|
|
|
|
Deferred taxes and long-term liabilities |
|
| 6,826 |
|
| 5,098 |
|
|
|
|
|
|
|
|
|
Commitments and contingencies |
|
| — |
|
| — |
|
|
|
|
|
|
|
|
|
Total shareholders’ equity - Zygo Corporation |
|
| 174,835 |
|
| 173,625 |
|
Noncontrolling interest(s) |
|
| 1,555 |
|
| 2,355 |
|
|
|
|
| ||||
Total equity |
|
| 176,390 |
|
| 175,980 |
|
|
|
|
| ||||
Total liabilities and equity |
| $ | 205,971 |
| $ | 210,021 |
|
|
|
|
| ||||
5
|
Zygo Corporation and Subsidiaries |
Reconciliation of Reported Results to Non-GAAP Results |
(Unaudited) |
(Amounts in thousands, except per share amounts)
|
|
|
|
|
|
|
|
|
| Three Months Ended |
| ||||
|
|
| |||||
|
| 2012 |
| 2011 |
| ||
|
|
|
| ||||
| |||||||
GAAP Income before income tax, including noncontrolling interest (as reported) |
| $ | 4,427 |
| $ | 7,762 |
|
|
|
|
| ||||
Net income attributable to noncontrolling interest (as reported) |
|
| 606 |
|
| 507 |
|
| |||||||
GAAP income tax expense (as reported) |
|
| (1,433 | ) |
| (786 | ) |
Adjustment to income taxes(Note 1) |
|
| (398 | ) |
| — |
|
|
|
|
| ||||
Total adjusted income tax expense |
| $ | (1,831 | ) | $ | (786 | ) |
|
|
|
| ||||
|
|
|
|
|
|
|
|
Adjusted net income attributable to Zygo Corporation |
| $ | 1,990 |
| $ | 6,469 |
|
|
|
|
| ||||
GAAP earnings per diluted share attributable to Zygo Corporation (as reported) |
| $ | 0.13 |
| $ | 0.35 |
|
Adjusted earnings per diluted share attributable to Zygo Corporation |
| $ | 0.10 |
| $ | 0.35 |
|
Weighted average shares used in diluted shares calculation |
|
| 19,047 |
|
| 18,353 |
|
Note 1 - The Company’s first quarter fiscal 2013 reported results include adjustments to correct an error in recording deferred tax asset balances as of June 30, 2012, relating to fixed assets and foreign tax credits.
Adjusted net income and adjusted net earnings per diluted share are operating performance measures defined by the Company and used by the Company’s management to evaluate its operating activities, and a reconciliation of such amounts to reported results is presented above. These non-GAAP measures are not alternatives to, and are not intended to replace, the most directly comparable reported measures under GAAP and should not be considered as alternatives to net income and net earnings per diluted share, or any other measure of consolidated operating results, under GAAP. The Company believes that providing such non-GAAP measures and reconciliation is useful to users of the financial statements, since such measures involve certain significant and unusual adjustments to the Company’s results, thus enhancing comparability of the Company’s results between periods presented.
6